Weekly Recap | Alnylam Pharma -6.55%, consensus target above spotWeekly Review·Sep 12 at 05:55 AMALNY-4.69%
Weekly Recap | Alnylam Pharma +12.24%, most brokers rate it buyWeekly Review·Sep 5 at 06:03 AMALNY-4.69%
